Preventing, delaying, or masking type 2 diabetes with metformin in the Diabetes Prevention Program? [10] (multiple letters)

Diabetes Care

Volumn 26, Issue 9, 2003, Pages 2701-2703

  Scheen, Andre J ^a   Buchanan, Thomas A ^b,c   Molitch, Mark E ^d  

^a CHU SART TILMAN   (Belgium)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c George Washington University ^*  (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; METFORMIN; PLACEBO; TROGLITAZONE;

DRUG EFFICACY; DRUG HALF LIFE; GLUCOSE CLAMP TECHNIQUE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; ISOTOPE DILUTION ASSAY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; REPRODUCIBILITY OF RESULTS;

EID: 0042323079     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.9.2701     Document Type: Letter

References (0)